ReviewCell biochemistry and biophysics2026
MicroRNAs as Mediators of Mechanotransduction: from Fundamental Mechanisms to Therapeutic Applications.
Review in Cell biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Essential Role of Integrin-Linked Kinase in Keratinocyte Responses to Mechanical Strain.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MicroRNAs (miRNAs) are key gene expression regulators involved in essential cellular processes. They also mediate mechanotransduction, translating mechanical cues like shear stress, tensile forces, and ECM stiffness into intracellular signals. This review examines the bidirectional relationship between mechanical stimuli and miRNAs: how mechanical cues regulate miRNA biogenesis and how specific miRNAs (e.g., miR-10a, miR-19a, miR-143/145) modulate Hippo-YAP/TAZ and Wnt pathways to control cytoskeletal dynamics, proliferation, differentiation, and apoptosis. Dysregulation of these mechanosensitive miRNAs is implicated in fibrosis, cancer metastasis, cardiovascular diseases, and musculoskeletal disorders, where disrupted mechanical signaling affects tissue homeostasis. We also explore the therapeutic potential of targeting the miRNA-mechanical axis, including miRNA replacement for downregulated miRNAs (e.g., miR-29) and antagomiRs to inhibit pathogenic miRNAs (e.g., miR-21). This review emphasizes the central role of miRNAs in mechanobiology and their potential for novel diagnostic and therapeutic applications across diverse human diseases.
Indexed as
Identifiers
41144194What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.